Cancer
Neoplasm of Uncertain Histogenesis
CI-CAN-00000034Explore in graph →
Non-malignant20,291 active trials259 approved drugs3,814 evidence items
Loading cancer entity…
Cancer
CI-CAN-00000034Explore in graph →
Clinical trials
91,377 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06406127 | Effect of Alpha Lipoic Acid on Chemotherapy Induced Neurological Changes in Breast Cancer Patients | unknown | Phase 4 | 92 | Ain Shams UniversityOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06406322 | Pelvic Floor Dysfunction and Aerobic Training in Gynecological Cancer | unknown | N/A | 40 | Atılım UniversityOTHER | 0 | May 9, 2024 | clinicaltrials |
| NCT06406556 |
| Safety & Efficacy of Peg-ASP-based CCRT in Early Stage ENKTL(ENKTL) |
| unknown |
| Phase 2 |
| 90 |
| Sun Yat-sen UniversityOTHER |
| 1 |
| May 9, 2024 |
| clinicaltrials |
| NCT06406608 | Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer | unknown | N/A | 20 | Henan Cancer HospitalOTHER_GOV | 1 | May 9, 2024 | clinicaltrials |
| NCT06406660 | Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer | unknown | N/A | 20 | Henan Cancer HospitalOTHER_GOV | 1 | May 9, 2024 | clinicaltrials |
| NCT06406868 | Outpatient Versus Tele Rehabilitation Among Post-surgical Breast Cancer Survivors | unknown | N/A | 44 | Riphah International UniversityOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT01064635 | Letrozole in Treating Breast Cancer in Postmenopausal Women With Stage I, II, or III Breast Cancer Previously Treated With Tamoxifen (GIM4)(GIM4) | unknown | Phase 3 | 2,056 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT02509286 | Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus(ESOPEC) | unknown | Phase 3 | 438 | University Hospital Schleswig-HolsteinOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT03632603 | PAlliative RAdioTherapy to Lung Cancer A Randomized Multicentre Phase III Study(PARAT) | unknown | Phase 3 | 1,184 | University of AarhusOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT05039762 | Intracorporeal vs. Extracorporeal Anastomosis in Patients Undergoing Laparoscopic Right Hemicolectomy for Colonic Cancer(ICEA) | unknown | N/A | 104 | University of Southern DenmarkOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT05115799 | Effects of a Manual Therapy Program to Reduce the Evolution Time of Axillary Web Syndrome | unknown | N/A | 46 | University of MalagaOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT05441722 | CIPN in Early Stage Breast Cancer Patients | unknown | N/A | 48 | Northumbria UniversityOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT05657080 | Cytosponge for Gastric Intestinal Metaplasia(CyGIM) | unknown | — | 226 | University of CambridgeOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT05758610 | A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients | unknown | Phase 1 | 60 | Shengke Pharmaceuticals (Jiangsu) Limited, ChinaINDUSTRY | 1 | May 8, 2024 | clinicaltrials |
| NCT06403878 | Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer | unknown | Phase 2 | 68 | Sichuan UniversityOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT06403904 | Assessing Clinical Features and Outcome of Breast Cancer in PALB2 Mutation Carriers: the Palbreast Study(PALBREAST) | unknown | — | 600 | Azienda Ospedaliero-Universitaria di ModenaOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT06403917 | Evaluation of Breast Cancer Screening Program at Assiut Governorate | unknown | — | 15,000,000 | Assiut UniversityOTHER | 0 | May 8, 2024 | clinicaltrials |
| NCT06404840 | Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study | unknown | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT06405009 | Prediction Model of Occult Omental Metastasis in Patients With Gastric Cancer | unknown | — | 450 | Northern Jiangsu People's HospitalOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT06405035 | Dissecting the Role of MIcrobioMe in gastroEsophageal Tumor: a multIdisCiplinary Longitudinal Study(MIMETIC) | unknown | — | 140 | European Institute of OncologyOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT06405685 | Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis | unknown | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT03292263 | ASCT With Nivolumab in Patients With Multiple Myeloma | unknown | Phase 1 / Phase 2 | 30 | St. Petersburg State Pavlov Medical UniversityOTHER | 1 | May 7, 2024 | clinicaltrials |
| NCT03804580 | First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung Cancer(FIOL) | unknown | Phase 2 | 100 | Vestre Viken Hospital TrustOTHER | 4 | May 7, 2024 | clinicaltrials |
| NCT05081141 | HHV8 and Solid Organ Transplantation | unknown | — | 250 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoOTHER | 1 | May 7, 2024 | clinicaltrials |
| NCT05354102 | A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128 | unknown | Phase 1 | 11 | Biomica Ltd.INDUSTRY | 1 | May 7, 2024 | clinicaltrials |
| NCT05443646 | Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients | unknown | Phase 2 | 55 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | May 7, 2024 | clinicaltrials |
| NCT05635266 | Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives | unknown | — | 20,000 | Sanguine BiosciencesINDUSTRY | 1 | May 7, 2024 | clinicaltrials |
| NCT06115239 | QOL After SURGERY and ADJUVANT Treatment | unknown | — | 200 | University of SalamancaOTHER | 1 | May 7, 2024 | clinicaltrials |
| NCT06325891 | Microbiota in Gastric Cancer by Gastric Mucosal Brushing | unknown | — | 40 | King Chulalongkorn Memorial HospitalOTHER | 1 | May 7, 2024 | clinicaltrials |
| NCT06402695 | Observational Study on GEP-and Pulm-NET Treated at FPG(ETNA-FPG) | unknown | — | 650 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | May 7, 2024 | clinicaltrials |
| NCT06078787 | Olaparib in PALB2 Advanced Pancreatic Cancer(PALBOLA) | unknown | Phase 2 | 16 | Azienda Ospedaliero-Universitaria di ModenaOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT06400654 | PrognostIc and Predictive Factors in Unresectable Locally Advanced NEC and MANEC(NIRVANA) | unknown | — | 100 | European Institute of OncologyOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT00892866 | CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells | unknown | N/A | 877 | GOG FoundationNETWORK | 3 | May 3, 2024 | clinicaltrials |
| NCT01649089 | Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer | unknown | N/A | 224 | GOG FoundationNETWORK | 3 | May 3, 2024 | clinicaltrials |
| NCT03296150 | ADOPT-PRESTAGE: Study Evaluating the Impact of the Program PRESTAGE(ADOPT-PRESTAGE) | unknown | N/A | 139 | Hospices Civils de LyonOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT03833440 | Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance(PIONeeR) | unknown | Phase 2 | 114 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT04029181 | ImmunoPET With an Anti-CD8 Imaging Agent | unknown | Phase 1 / Phase 2 | 47 | University Medical Center GroningenOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT04193956 | POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors(POINTING) | unknown | — | 3,500 | University Medical Center GroningenOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT04715438 | Vaccination Against COVID-19 in Cancer(VOICE) | unknown | N/A | 791 | University Medical Center GroningenOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT06081686 | Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer | unknown | Phase 1 / Phase 2 | 32 | Sinotau Pharmaceutical GroupINDUSTRY | 1 | May 3, 2024 | clinicaltrials |
| NCT06381960 | Clinical Study on the Prevention and Treatment of Postoperative Metastasis of Lung Cancer by Fuzheng Quxie Recipe | unknown | Phase 2 | 356 | Jianhui TianOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT06397807 | Postoperative Pain Management on Patients Undergoing Lung Tumor Resection | unknown | — | 400 | China Medical University HospitalOTHER | 0 | May 3, 2024 | clinicaltrials |
| NCT06398405 | A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer | unknown | Phase 2 | 72 | Shandong Cancer Hospital and InstituteOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT03993106 | A Study of sEphB4-HSA in Kaposi Sarcoma | unknown | Phase 2 | 65 | Vasgene Therapeutics, IncINDUSTRY | 1 | May 2, 2024 | clinicaltrials |
| NCT04486781 | A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma | unknown | Phase 2 | 38 | Vasgene Therapeutics, IncINDUSTRY | 1 | May 2, 2024 | clinicaltrials |
| NCT06395337 | Multimodal Imaging in Rectal Cancer & Pancreatic Cancer(MIRCA & MIPAC) | unknown | Phase 1 / Phase 2 | 20 | Radboud University Medical CenterOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT06395766 | Assessment of Quality of Life and Social Support Gained in Patients Before and After Colorectal Cancer Surgery | unknown | — | 100 | Andrzej Frycz Modrzewski Krakow UniversityOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT06396143 | Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration | unknown | — | 120 | Zhejiang UniversityOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT03466944 | PUMA (Paediatric Osseous Marrow Assessment)(PUMA) | unknown | — | 12 | Institute of Cancer Research, United KingdomOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT04557020 | Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC | unknown | Phase 3 | 200 | Jiangxi Provincial Cancer HospitalOTHER | 1 | May 1, 2024 | clinicaltrials |
Data updated 24 days agoSource updated May 9, 2024source: clinicaltrials